• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌最新进展:胃癌、可靠的治疗方法及潜在益处

Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.

作者信息

Graham David Y

机构信息

Department of Medicine, Michael E. DeBakey VA Medical Center, and Baylor College of Medicine, Houston, Texas.

出版信息

Gastroenterology. 2015 Apr;148(4):719-31.e3. doi: 10.1053/j.gastro.2015.01.040. Epub 2015 Feb 2.

DOI:10.1053/j.gastro.2015.01.040
PMID:25655557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4375058/
Abstract

Helicobacter pylori infection contributes to the development of diverse gastric and extragastric diseases. The infection is necessary but not sufficient for the development of gastric adenocarcinoma. Its eradication would eliminate a major worldwide cause of cancer death, therefore there is much interest in identifying how, if, and when this can be accomplished. There are several mechanisms by which H pylori contributes to the development of gastric cancer. Gastric adenocarcinoma is one of many cancers associated with inflammation, which is induced by H pylori infection, yet the bacteria also cause genetic and epigenetic changes that lead to genetic instability in gastric epithelial cells. H pylori eradication reduces both. However, many factors must be considered in determining whether treating this bacterial infection will prevent cancer or only reduce its risk-these must be considered in designing reliable and effective eradication therapies. Furthermore, H pylori infection has been proposed to provide some benefits, such as reducing the risks of obesity or childhood asthma. When tested, these hypotheses have not been confirmed and are therefore most likely false.

摘要

幽门螺杆菌感染会促使多种胃部和胃外疾病的发生。这种感染是胃腺癌发生的必要条件,但并非充分条件。根除幽门螺杆菌将消除全球范围内癌症死亡的一个主要原因,因此人们对确定如何、是否以及何时能够实现这一目标非常感兴趣。幽门螺杆菌促使胃癌发生有多种机制。胃腺癌是与炎症相关的众多癌症之一,炎症由幽门螺杆菌感染诱发,然而这种细菌还会引起遗传和表观遗传变化,导致胃上皮细胞出现基因不稳定。根除幽门螺杆菌可降低这两者的发生率。但是,在确定治疗这种细菌感染是否会预防癌症或只是降低其风险时,必须考虑许多因素——在设计可靠且有效的根除疗法时必须考虑这些因素。此外,有人提出幽门螺杆菌感染有一些益处,比如降低肥胖或儿童哮喘的风险。经测试,这些假设未得到证实,因此很可能是错误的。

相似文献

1
Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.幽门螺杆菌最新进展:胃癌、可靠的治疗方法及潜在益处
Gastroenterology. 2015 Apr;148(4):719-31.e3. doi: 10.1053/j.gastro.2015.01.040. Epub 2015 Feb 2.
2
Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma.幽门螺杆菌根除治疗与 Barrett 食管和食管腺癌的风险。
Helicobacter. 2020 Jun;25(3):e12688. doi: 10.1111/hel.12688. Epub 2020 Mar 16.
3
Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study.幽门螺杆菌感染后胃癌的风险因素和发病情况:一项大型队列研究。
Gastroenterology. 2020 Feb;158(3):527-536.e7. doi: 10.1053/j.gastro.2019.10.019. Epub 2019 Oct 22.
4
eradication treatment and the risk of gastric adenocarcinoma in a Western population.根除治疗与西方人群胃腺癌风险。
Gut. 2018 Dec;67(12):2092-2096. doi: 10.1136/gutjnl-2017-315363. Epub 2018 Jan 30.
5
Recent Developments Pertaining to H. pylori Infection.幽门螺杆菌感染的近期进展
Am J Gastroenterol. 2021 Jan 1;116(1):1-3. doi: 10.14309/ajg.0000000000001031.
6
Oesophageal adenocarcinoma or gastric cancer with or without eradication of Helicobacter pylori infection in chronic atrophic gastritis patients: a hypothetical opinion from a systematic review.慢性萎缩性胃炎患者中伴有或不伴有幽门螺杆菌感染根除的食管腺癌或胃癌:基于系统评价的假设观点
Aliment Pharmacol Ther. 2004 Jul;20 Suppl 1:54-61. doi: 10.1111/j.1365-2036.2004.01975.x.
7
Eradication rate and histological changes after Helicobacter pylori eradication treatment in gastric cancer patients following subtotal gastrectomy.胃癌患者胃大部切除术后幽门螺杆菌根除治疗后的根除率及组织学变化。
World J Gastroenterol. 2015 Apr 7;21(13):3936-43. doi: 10.3748/wjg.v21.i13.3936.
8
Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.幽门螺杆菌治疗对老年人胃癌发病率的影响。
Gastroenterology. 2018 Jul;155(1):67-75. doi: 10.1053/j.gastro.2018.03.028. Epub 2018 Mar 14.
9
[Esophageal adenoma-carcinoma and Barrett's esophagus. Gastric adenocarcinoma and Helicobacter pylori].[食管腺瘤-癌与巴雷特食管。胃腺癌与幽门螺杆菌]
Gastroenterol Hepatol. 2008 Oct;31 Suppl 4:66-9. doi: 10.1016/s0210-5705(08)76633-0.
10
Effect of Helicobacter pylori eradication and high-density lipoprotein on the risk of de novo gastric cancer development.幽门螺杆菌根除和高密度脂蛋白对新发胃癌发展风险的影响。
Gastrointest Endosc. 2019 Sep;90(3):448-456.e1. doi: 10.1016/j.gie.2019.04.232. Epub 2019 Apr 26.

引用本文的文献

1
Bismuth Quadruple Therapy with Doxycycline Is an Effective First-Line Therapy for in an Irish Cohort.在爱尔兰队列中,含强力霉素的铋四联疗法是治疗幽门螺杆菌感染的有效一线疗法。 需注意,你提供的原文中“for in an Irish Cohort”表述不完整,推测这里应该是“for Helicobacter pylori infection in an Irish Cohort”之类,我按照补充完整后的意思进行了翻译,你可根据实际情况调整。
Antibiotics (Basel). 2025 Jul 28;14(8):757. doi: 10.3390/antibiotics14080757.
2
Prevalence of infection among dyspeptic patients attending Baghdad medical city complex.巴格达医学城综合医院消化不良患者的感染患病率。
Iran J Microbiol. 2025 Jun;17(3):397-403. doi: 10.18502/ijm.v17i3.18822.
3

本文引用的文献

1
Changing the natural history of metachronous gastric cancer after eradication.根除术后异时性胃癌自然史的改变
Jpn J Helicobacter Res. 2015;16(2):42-50.
2
Kyoto global consensus report on Helicobacter pylori gastritis.《京都幽门螺杆菌胃炎全球共识报告》
Gut. 2015 Sep;64(9):1353-67. doi: 10.1136/gutjnl-2015-309252. Epub 2015 Jul 17.
3
Why did ancient people have atherosclerosis?: from autopsies to computed tomography to potential causes.为什么古代人会患动脉粥样硬化?:从尸检到计算机断层扫描再到潜在病因
-Induced Apoptosis in Gastric Diseases: Mechanisms, Implications, and Diagnostic Applications.
- 胃部疾病中的诱导性细胞凋亡:机制、意义及诊断应用
Int J Gen Med. 2025 Jun 10;18:2995-3009. doi: 10.2147/IJGM.S520982. eCollection 2025.
4
Targeted nanomedicines for the treatment of infection.用于治疗感染的靶向纳米药物。
Mater Today Bio. 2025 Apr 30;32:101820. doi: 10.1016/j.mtbio.2025.101820. eCollection 2025 Jun.
5
Enhancing diagnostic accuracy: Role of stomach-specific serum biomarkers in real-world risk-based sequential screening for malignant gastric lesions.提高诊断准确性:胃特异性血清生物标志物在基于风险的真实世界恶性胃病变序贯筛查中的作用。
Chin J Cancer Res. 2025 Apr 30;37(2):154-164. doi: 10.21147/j.issn.1000-9604.2025.02.03.
6
Association of Proton Pump Inhibitor Use With Gastric Cancer in Regions With High Prevalence of Gastric Cancer: Systematic Review and Meta-analysis.胃癌高发地区质子泵抑制剂使用与胃癌的关联:系统评价与荟萃分析
J Neurogastroenterol Motil. 2025 Apr 30;31(2):178-185. doi: 10.5056/jnm24145.
7
Real Way to Target Gram-Negative Pathogens: Discovery of a Novel Antibiotic Class.靶向革兰氏阴性病原体的真正方法:新型抗生素类别的发现
J Med Chem. 2025 May 22;68(10):10128-10138. doi: 10.1021/acs.jmedchem.5c00112. Epub 2025 Mar 31.
8
Declining eradication rates of with standard triple therapy in Addis Ababa, Ethiopia.在埃塞俄比亚亚的斯亚贝巴,标准三联疗法的根除率正在下降。
World J Gastroenterol. 2025 Feb 21;31(7):97401. doi: 10.3748/wjg.v31.i7.97401.
9
The Role of TP53, KRAS, CDH1, Demographic and Clinical Variables in Gastric Cancer.TP53、KRAS、CDH1、人口统计学和临床变量在胃癌中的作用
Mater Sociomed. 2024;36(4):280-287. doi: 10.5455/msm.2024.36.280-287.
10
-targeted AI-driven vaccines: a paradigm shift in gastric cancer prevention.靶向人工智能驱动的疫苗:胃癌预防的范式转变。
Front Immunol. 2024 Nov 28;15:1500921. doi: 10.3389/fimmu.2024.1500921. eCollection 2024.
Glob Heart. 2014 Jun;9(2):229-37. doi: 10.1016/j.gheart.2014.04.002.
4
Computed tomographic evidence of atherosclerosis in the mummified remains of humans from around the world.世界各地木乃伊化人类遗骸中动脉粥样硬化的计算机断层扫描证据。
Glob Heart. 2014 Jun;9(2):187-96. doi: 10.1016/j.gheart.2014.03.2455.
5
The Diagnostic Validity of Citric Acid-Free, High Dose (13)C-Urea Breath Test After Helicobacter pylori Eradication in Korea.韩国幽门螺杆菌根除后无柠檬酸高剂量(13)C-尿素呼气试验的诊断有效性
Helicobacter. 2015 Jun;20(3):159-68. doi: 10.1111/hel.12189. Epub 2015 Jan 29.
6
[Overweight and obesity among children in nurseries].[托儿所儿童中的超重与肥胖问题]
Rev Med Inst Mex Seguro Soc. 2014 Nov-Dec;52(6):606-9.
7
Age, period, and cohort effects on gastric cancer mortality.年龄、时期和队列效应对胃癌死亡率的影响。
Dig Dis Sci. 2015 Feb;60(2):514-23. doi: 10.1007/s10620-014-3359-0. Epub 2014 Oct 2.
8
Prevalence of Helicobacter pylori infection and its relation with body mass index in a Chinese population.中国人群中幽门螺杆菌感染的患病率及其与体重指数的关系。
Helicobacter. 2014 Dec;19(6):437-42. doi: 10.1111/hel.12153. Epub 2014 Sep 25.
9
Helicobacter pylori and extragastric diseases.幽门螺杆菌与胃外疾病
Helicobacter. 2014 Sep;19 Suppl 1:52-8. doi: 10.1111/hel.12159.
10
Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions.胃癌前病变患者内镜监测的成本效用分析
Helicobacter. 2014 Dec;19(6):425-36. doi: 10.1111/hel.12150. Epub 2014 Aug 28.